EDTUTC-4 New YorkLog in Sign up

PVLA
Palvella Therapeutics, Inc. Common Stock
stockNASDAQ

Market OpenOct 5, 2026 10:43:45 AM EDT

129.60USD-2.248%(-2.98)36,509

128.75Bid149.04Ask20.29Spread

Loading…

Loading…

1.87B

Previous Close

$132.33

Beta

1.65

52-Week High

$161.38 2026-06-30

52-Week Low

$65.93 2025-10-10

SMA 50

$148.71

SMA 200

$123.76

Avg. Vol 10D

231,666

Avg. Vol 30D

223,234

Avg. Vol 90D

243,830

Relative Vol

0.16

14.41M

9.62M

66.78%

2,325,699

Short Interest %

24.17%

12.82

On/Off Exchange

57%/43%

50.77%

Short Vol % (off-exch)

37.55%

0.2900%

75,000

779

1,426

4,944

Nov 10, 2026 (36d)

Oct 2, 2026

04:34 PM EDTPalvella Therapeutics is Now Oversold (PVLA) ·

BNK Invest

Sep 28, 2026

07:30 AM EDTU.S. Food and Drug Administration Awards Additional Funding for QTORIN™ Rapamycin for the Treatment of Microcystic Lymphatic Malformations ·

GlobeNewswire Inc.

Sep 15, 2026

09:45 PM EDTPalvella Therapeutics director George M Jenkins sells $4.17 million in shares ·

Investing.com

PVLA Performance

Period	Price	Date	Change	Beta
1W	139.83	2026-09-28	-7.34%	0.263
1M	157.24	2026-09-04	-17.60%	0.867
3M	140.31	2026-07-06	-7.66%	1.555
6M	119.86	2026-04-06	+8.10%	1.385
1Y	67.95	2025-10-06	+90.67%	1.649
2Y	12.83	2024-12-16	+909.85%	—

PVLA Stock Summary

Palvella Therapeutics, Inc. Common Stock (NASDAQ:PVLA) stock price today is $129.56, and today's volume is 36,022. PVLA is down 2.194% today. The 30 day average volume is 223,234. PVLA market cap is $1.87B with 14.41M shares outstanding.